0000000000343756

AUTHOR

Mark W. Elliott

showing 2 related works from this author

Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections

2020

ABSTRACTIntroductionNoninvasive respiratory support (NRS) such as noninvasive ventilation (NIV) and high flow nasal therapy (HFNT) have been used in the treatment of acute hypoxemic respiratory failure (AHRF) related to the coronavirus disease (COVID-19) and other viral infections. However, there is a lack of consensus in favor of or against NRS use due to the risks of worsening hypoxemia, intubation delay, and aerosols environmental contamination associated with the use of these tools. We aimed to summarize the evidence on the use of NRS in adult patients with COVID-19 and other viral pneumonia (i.e. H1N1, SARS, MERS) and AHRF. We also searched for studies evaluating the risk of aerosoliza…

Adultmedicine.medical_specialtyContext (language use)Diseasemedicine.disease_causeHIGH FLOW NASAL THERAPYAirborne transmissionHFNCHypoxemialaw.invention03 medical and health sciences0302 clinical medicineInfluenza A Virus H1N1 SubtypeRandomized controlled trial030202 anesthesiologylawmedicineHumansCOVID-19; Noninvasive ventilation Pneumonia viral Adult Humans Pandemics SARS-CoV-2 COVID-19 Coronavirus. Influenza A Virus H1N1 Subtype Noninvasive Ventilation Respiratory InsufficiencyH1N1 SubtypeIntensive care medicinePandemicsAerosolizationCoronavirusNoninvasive VentilationPneumonia viralSARS-CoV-2business.industryCOVID-19030208 emergency & critical care medicinemedicine.diseaseCoronavirusAnesthesiology and Pain MedicineCoronavirus. Influenza A VirusViral pneumoniamedicine.symptomRespiratory InsufficiencybusinessHFNT
researchProduct

European Respiratory Society statement on sleep apnoea, sleepiness and driving risk

2021

Obstructive sleep apnoea (OSA) is highly prevalent and is a recognised risk factor for motor vehicle accidents (MVA). Effective treatment with continuous positive airway pressure has been associated with a normalisation of this increased accident risk. Thus, many jurisdictions have introduced regulations restricting the ability of OSA patients from driving until effectively treated. However, uncertainty prevails regarding the relative importance of OSA severity determined by the apnoea–hypopnoea frequency per hour and the degree of sleepiness in determining accident risk. Furthermore, the identification of subjects at risk of OSA and/or accident risk remains elusive. The introduction of off…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAutomobile DrivingSleepinessmedia_common.quotation_subjectmedicine.medical_treatmentPoison controlSettore MED/10 - Malattie Dell'Apparato RespiratorioSleep ApnoeaSuicide preventionOccupational safety and healthDriving Simulators03 medical and health sciences0302 clinical medicineRisk FactorsEpidemiologyInjury preventionSleep Apnoea Driving Accident Risk Sleepiness Screening Driving Simulators Treatment RegulationsmedicineHumansContinuous positive airway pressureIntensive care medicineRegulationsmedia_commonSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryAccidents TrafficHuman factors and ergonomicsnervous system diseasesrespiratory tract diseasesTreatment030228 respiratory systemAccident RiskScreeningHuman medicinebusiness030217 neurology & neurosurgeryDrivingVigilance (psychology)
researchProduct